bioAffinity Technologies (BIAF) EBT Margin (2022 - 2026)
bioAffinity Technologies (BIAF) posted quarterly EBT Margin of 268.63% for Q1 2026, down 12557.0% year-over-year from N/an in Q1 2025, and down 36.52% quarter-over-quarter from 196.78% in Q4 2025.
bioAffinity Technologies (BIAF) EBT Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported EBT Margin for 5 consecutive years, with 268.63% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin fell 12557.0% year-over-year to 268.63%; the TTM figure through Mar 2026 stood at 279.95% (down 16959.0% YoY), while the FY2025 annual figure was 241.25%, down 14482.0% from the prior year.
- EBT Margin retreated to 268.63% in Q1 2026 per BIAF's latest filing, from 196.78% in the prior quarter.
- Across five years, EBT Margin topped out at 81.37% in Q1 2024 and bottomed at 427752.87% in Q3 2022.
- Historically, EBT Margin has averaged 42646.84% across 5 years, with a median of 293.11% in 2025.
- On a YoY basis, EBT Margin climbed as much as 42698613 bps in 2023 and fell as far as 205101 bps in 2023.
- bioAffinity Technologies' EBT Margin stood at 71380.39% in 2022, then soared by 100 bps to 107.12% in 2023, then dropped by 25 bps to 134.4% in 2024, then slumped by 46 bps to 196.78% in 2025, then plunged by 37 bps to 268.63% in 2026.
- Business Quant data shows BIAF's EBT Margin at 268.63% in Q1 2026, 196.78% in Q4 2025, and 349.08% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - | -268.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -268.63% |
| Dec 31, 2025 | -196.78% |
| Sep 30, 2025 | -349.08% |
| Jun 30, 2025 | -317.59% |
| Mar 31, 2025 | -143.06% |
| Dec 31, 2024 | -134.40% |
| Sep 30, 2024 | -85.02% |
| Jun 30, 2024 | -87.79% |
| Mar 31, 2024 | -81.37% |
| Dec 31, 2023 | -107.12% |
| Sep 30, 2023 | -766.74% |
| Jun 30, 2023 | -8,793.12% |
| Mar 31, 2023 | -165,143.43% |
| Dec 31, 2022 | -71,380.39% |
| Sep 30, 2022 | -427,752.87% |
| Jun 30, 2022 | -6,742.11% |